Furthermore, the inhibitors SCH772984 and BP-1-102 demonstrated effective inhibition of the MAPK/ERK and JAK/STAT pathways, respectively, in all HNSCC cell lines tested (Figure 3A,B and Figure S3A,B). This evidence concerns the gene SOAT1 and head and neck squamous cell carcinoma.